rs13361707
|
|
|
0.780 |
GeneticVariation |
BEFREE |
In similar, an increased risk of gastric cancer was also observed for rs13361707</span> TC genotype (adjusted OR = 1.47, 95%CI: 1.01-2.14, p = 0.043; additive model: adjusted OR = 1.22, 95%CI: 1.02-1.47, p = 0.033).
|
30253744 |
2018 |
rs13361707
|
|
|
0.780 |
GeneticVariation |
BEFREE |
TLR1 rs4833095 SNP was associated with an increased risk of GC in a European population, while PRKAA1 rs13361707 genetic variant was not linked with GC.
|
30574617 |
2018 |
rs13361707
|
|
|
0.780 |
GeneticVariation |
BEFREE |
The meta-analysis reveals that the PRKAA1 rs13361707 T>C polymorphism has a significant relationship with increased GC risk.
|
29620653 |
2018 |
rs13361707
|
|
|
0.780 |
GeneticVariation |
BEFREE |
Correlation between protein kinase catalytic subunit alpha-1 gene rs13361707 polymorphism and gastric cancer susceptibility in asian populations.
|
28978122 |
2017 |
rs13361707
|
|
|
0.780 |
GeneticVariation |
BEFREE |
In summary, these results indicated that the C allele of PRKAA1 rs13361707 was a low-penetrate risk factor for GCa.
|
26485766 |
2015 |
rs13361707
|
|
|
0.780 |
GeneticVariation |
BEFREE |
In the dominant model, SNPs rs13361707 [odds ratio (OR) = 1.51, 95%CI: 1.07-2.11)], rs154268 (OR = 1.65, 95%CI: 1.22-2.22), rs6882903 (OR = 1.48, 95%CI: 1.09-2.00), and rs10074991 (OR = 1.53, 95%CI: 1.09-2.16) were significantly associated with an increased risk of gastric cancer.
|
25024613 |
2014 |
rs13361707
|
|
|
0.780 |
GeneticVariation |
BEFREE |
These findings indicate that the three SNPs (rs4072037, rs13361707 and rs2274223) identified in the GWASs may interact with H. pylori infection to increase the risk of GC.
|
24069371 |
2013 |
rs13361707
|
|
|
0.780 |
GeneticVariation |
BEFREE |
Our study showed that the rs13361707 polymorphism was associated with increased risk of gastric cancer in a Korean population.
|
23861218 |
2013 |
rs10074991
|
|
|
0.720 |
GeneticVariation |
BEFREE |
Haplotype analysis indicated A-G-C-T-C-G haplotype (rs6882903, rs10074991, rs13361707, rs3805490, rs154268 and rs461404) is associated with increased risk of g</span>astric cancer (OR = 1.29, 95%CI: 1.02-1.62, p = 0.035).
|
30253744 |
2018 |
rs10074991
|
|
|
0.720 |
GeneticVariation |
BEFREE |
Most notably, subjects with a homozygous minor allele in SNP rs10074991 showed 2.15 times the risk of gastric cancer</span> as subjects without a minor allele.
|
25024613 |
2014 |
rs154268
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Furthermore, the rs154268 and rs461404 were also found associated with increased gastric cancer risk, which may be influenced by age, tumor type and differentiation, and tumor stage.
|
30253744 |
2018 |
rs6882903
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Haplotype analysis indicated A-G-C-T-C-G haplotype (rs6882903, rs10074991, rs13361707, rs3805490, rs154268 and rs461404) is associated with increased risk of gastric cancer (OR = 1.29, 95%CI: 1.02-1.62, p = 0.035).
|
30253744 |
2018 |
rs154268
|
|
|
0.020 |
GeneticVariation |
BEFREE |
In the recessive model, SNPs rs154268 (OR = 1.66, 95%CI: 1.22-2.26), rs3805486 (OR = 0.63, 95%CI: 0.46-0.85), and rs10074991 (OR = 1.47, 95%CI: 1.15-1.88) were significant risk or protective factors for gastric cancer.
|
25024613 |
2014 |
rs6882903
|
|
|
0.020 |
GeneticVariation |
BEFREE |
In the dominant model, SNPs rs13361707 [odds ratio (OR) = 1.51, 95%CI: 1.07-2.11)], rs154268 (OR = 1.65, 95%CI: 1.22-2.22), rs6882903 (OR = 1.48, 95%CI: 1.09-2.00), and rs10074991 (OR = 1.53, 95%CI: 1.09-2.16) were significantly associated with an increased risk of gastric cancer.
|
25024613 |
2014 |
rs3805490
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Haplotype analysis indicated A-G-C-T-C-G haplotype (rs6882903, rs10074991, rs13361707, rs3805490, rs154268 and rs461404) is associated with increased risk of gastric cancer (OR = 1.29, 95%CI: 1.02-1.62, p = 0.035).
|
30253744 |
2018 |
rs461404
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Furthermore, the rs154268 and rs461404 were also found associated with increased gastric cancer risk, which may be influenced by age, tumor type and differentiation, and tumor stage.
|
30253744 |
2018 |